Gebhardt, K.; Edemir, B.; Groß, E.; Nemetschke, L.; Kewitz-Hempel, S.; Moritz, R.K.C.; Sunderkötter, C.; Gerloff, D.
BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma. Cancers 2021, 13, 2393.
https://doi.org/10.3390/cancers13102393
AMA Style
Gebhardt K, Edemir B, Groß E, Nemetschke L, Kewitz-Hempel S, Moritz RKC, Sunderkötter C, Gerloff D.
BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma. Cancers. 2021; 13(10):2393.
https://doi.org/10.3390/cancers13102393
Chicago/Turabian Style
Gebhardt, Kathleen, Bayram Edemir, Elisabeth Groß, Linda Nemetschke, Stefanie Kewitz-Hempel, Rose K. C. Moritz, Cord Sunderkötter, and Dennis Gerloff.
2021. "BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma" Cancers 13, no. 10: 2393.
https://doi.org/10.3390/cancers13102393
APA Style
Gebhardt, K., Edemir, B., Groß, E., Nemetschke, L., Kewitz-Hempel, S., Moritz, R. K. C., Sunderkötter, C., & Gerloff, D.
(2021). BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma. Cancers, 13(10), 2393.
https://doi.org/10.3390/cancers13102393